Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sahay (Houston, United States of America), R. Holy (Houston, United States of America), S. Lyons (Burlingame, California, United States of America), E. Parsley (Burlingame, California, United States of America), M. Maurer (Burlingame, California, United States of America), J. Weers (Burlingame, California, United States of America). Inspiratory flow profiles of PAH patients with AOS™ device intended to administer inhaled vardenafil. 1461

Member's Comments

No comment yet.

Related content which might interest you: Inspiratory flow profiles of patients with severe COPD achieved through Autohaler, Diskus, Turbohaler and in vitro assessment of corresponding output characteristics Source: Eur Respir J 2003; 22: Suppl. 45, 409s Year: 2003 Peak inspiratory flow measured at different inhaler resistances in patients with asthma Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012 Effect of He-O2 breathing and inhaled salbutamol on expiratory flow limitation and dynamic hyperinflation in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002 Low maximum inspiratory flow index in patients with inhaler therapy Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019 Peak inspiratory flow rate during inhalation corticosteroid therapy in adult asthma Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Impulse oscillometry parameters of COPD patients during inspiration and expiration and the effect of tiotropium inhalation therapy Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008 Bronchodilator reversibility testing in COPD using an inspiratory peak flow meter Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Combination of electronically controlled breathing pattern and improved nebulizer technology for inhaled corticosteroid therapy of severe asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Assessment of inhaler technique using inspiratory flow measurement Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Peak inspiratory flow in patients with moderate or severe COPD using the Almirall inhaler Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Effect of sequential nebulised salbutamol therapy on peak expiratory flow rate Source: Eur Respir J 2005; 26: Suppl. 49, 507s Year: 2005 Influence from corticosteroids administered through inhalatory route in the maximal inspiratory pressure and maximal expiratory pressure in children with bronquial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 697s Year: 2004 Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD Source: Eur Respir J 2003; 21: 86-94 Year: 2003 Long acting bronchodilation of Spiriva® handihaler in COPD patients, the influence of the inhalation flow rate (IFR) Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 Inspiratory flow patterns with dry powder inhalers (DPIs) of low and medium flow resistance in subjects with pulmonary arterial hypertension (PAH) Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 Evaluation of a guided breathing manoeuvre for nebulised drug delivery in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 581s Year: 2004 Measurement of inspiratory flow through 3 different dry powder inhalation devices using In-check in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 493s Year: 2001 In vitro delivery of formoterol via a novel multi-dose dry powder inhaler, at clinically relevant inspiratory flow rates Source: Eur Respir J 2003; 22: Suppl. 45, 472s Year: 2003